Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies
Objective. Systemic inflammation response index (SIRI) is a new inflammation-based evaluation system that has been reported for predicting survival in multiple tumors, but the prognostic significance of SIRI in cancers has not been evinced. Methods. Eligible studies updated on December 31, 2019, wer...
Main Authors: | Yi Zhang, Fangteng Liu, Yang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2020/8854267 |
Similar Items
-
Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer
by: Jing Li, et al.
Published: (2020-01-01) -
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
by: Ye Qiu, et al.
Published: (2021-03-01) -
Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
by: Chen L, et al.
Published: (2020-03-01) -
The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
by: Jin B, et al.
Published: (2021-08-01) -
Prognostic value of systemic immune-inflammation index in patients with gastric cancer
by: Kang Wang, et al.
Published: (2017-09-01)